NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint ...
Investors are hereby notified that they have until 60 days from this notice to move the Court to serve as lead plaintiff in this action. On September 4, 2025, after the market closed, Quanex announced ...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quanex Building Products Corporation ...
Nurix Therapeutics (NRIX) announced the presentation of new clinical data from its first-in-human Phase 1a study of NX-1607, a first-in-class oral ...
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts ...
SAN DIEGO, Sept. 24, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Quanex Building Products ...
The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the District of Connecticut captioned Zanol v. Quanex Building Products ...
Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Quanex Building Products Corporation ("Quanex" or the ...